Quadruple therapy is a treatment used to eradicate the Helicobacter pylori bacteria and consists of a proton pump inhibitor, two antibiotics and a bismuth agent.
H. pylori is a bacterium that parasitizes the human stomach and is closely associated with the development of diseases such as chronic gastritis, peptic ulcer and stomach cancer. Therefore, patients who are positive for H. pylori generally need to undergo H. pylori eradication treatment, and the commonly used clinical treatment program is quadruple therapy.
Quadruple therapy consists of a proton pump inhibitor (omeprazole, lansoprazole, etc.), plus two antibiotics (amoxicillin, clarithromycin, tetracycline, metronidazole, norfloxacin, etc.), and then combined with a bismuth agent (bismuth pectin, etc.). The course of treatment is usually 14 days, and is repeated one month after stopping the medication.
There may be some side effects during the treatment of quadruple therapy, such as nausea, loss of appetite, abdominal discomfort, black stools, etc. It should be used with caution for pregnant women, lactating women, and those with liver or kidney insufficiency, and alcohol consumption is strictly prohibited during the treatment.
For patients who are positive for Helicobacter pylori, it is recommended that they seek medical attention in a timely manner and use reasonable medication under the guidance of a physician for eradication treatment.